Cascades (TSE:CAS - Get Free Report) had its price target cut by equities researchers at CIBC from C$13.00 to C$10.00 in a research report issued to clients and investors on Tuesday,BayStreet.CA reports. The firm currently has a "neutral" rating on the stock. CIBC's price target would suggest a potential upside of 9.53% from the stock's current price.
A number of other analysts have also recently issued reports on the stock. Scotiabank upgraded shares of Cascades from a "hold" rating to a "strong-buy" rating and raised their target price for the stock from C$12.00 to C$15.50 in a research note on Monday, January 27th. Royal Bank of Canada cut their target price on Cascades from C$13.00 to C$11.00 and set a "sector perform" rating for the company in a research report on Tuesday. Finally, TD Securities reduced their target price on Cascades from C$16.00 to C$12.00 and set a "buy" rating on the stock in a report on Thursday, April 17th.
View Our Latest Analysis on CAS
Cascades Stock Up 0.7 %
TSE CAS traded up C$0.06 during trading hours on Tuesday, hitting C$9.13. 137,006 shares of the company traded hands, compared to its average volume of 225,951. Cascades has a twelve month low of C$8.83 and a twelve month high of C$13.42. The stock has a market capitalization of C$923.51 million, a price-to-earnings ratio of -12.31, a P/E/G ratio of 0.56 and a beta of 0.15. The company has a debt-to-equity ratio of 121.37, a quick ratio of 0.86 and a current ratio of 1.22. The business's 50-day moving average is C$10.34 and its 200-day moving average is C$11.23.
Insider Activity
In other Cascades news, Senior Officer Luc Langevin sold 9,000 shares of the company's stock in a transaction on Thursday, March 27th. The shares were sold at an average price of C$9.82, for a total transaction of C$88,380.00. 23.78% of the stock is currently owned by company insiders.
Cascades Company Profile
(
Get Free Report)
Cascades Inc produces, converts, and markets packaging and tissue products in Canada and the United States. The company operates through three segments: Containerboard, Specialty Products, and Tissue Papers. It offers various packaging solutions and tissue products comprised of recycled fibers; tissue papers, comprising parent rolls of virgin and recycled fibres; specialty products, including uncoated recycled boxboards; and containerboards.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cascades, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cascades wasn't on the list.
While Cascades currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.